Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Immunome Inc.

    NASDAQ: IMNM · Real-Time Price · USD
    9.14
    0.12 (1.33%)
    At close: Jun 05, 2025, 3:59 PM
    9.00
    -1.53%
    After-hours: Jun 05, 2025, 07:58 PM EDT

    Immunome Statistics

    Share Statistics

    Immunome has 87.01M shares outstanding. The number of shares has increased by 44.99% in one year.

    Shares Outstanding

    n/a
    		 87.01M

    Shares Change (YoY)

    n/a
    		 44.99%

    Shares Change (QoQ)

    n/a
    		 39.31%

    Owned by Institutions (%)

    n/a
    		 88.55%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 14,160

    FTD / Avg. Volume

    n/a
    		 1.24%

    Short Selling Information

    The latest short interest is 12.72M, so 14.62% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 12.72M

    Short % of Shares Out

    n/a
    		 14.62%

    Short % of Float

    n/a
    		 15.27%

    Short Ratio (days to cover)

    n/a
    		 12.49

    Valuation Ratios

    The PE ratio is -2.13 and the forward PE ratio is -3.79. Immunome's PEG ratio is 0.3.

    PE Ratio

    n/a
    		 -2.13

    Forward PE

    n/a
    		 -3.79

    PS Ratio

    n/a
    		 68.88

    Forward PS

    n/a
    		 2.9

    PB Ratio

    n/a
    		 3.44

    P/FCF Ratio

    n/a
    		 -5.28

    PEG Ratio

    n/a
    		 0.3
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Immunome.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 4.08, with a Debt / Equity ratio of 0.03.

    Current Ratio

    n/a
    		 4.08

    Quick Ratio

    n/a
    		 4.08

    Debt / Equity

    n/a
    		 0.03

    Debt / EBITDA

    n/a
    		 -0.03

    Debt / FCF

    n/a
    		 -0.04

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $69,015.27

    Profits Per Employee

    n/a
    		 $-2,236,358.78

    Employee Count

    n/a
    		 131

    Asset Turnover

    n/a
    		 0.04

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -39.67% in the last 52 weeks. The beta is 1.95, so Immunome's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.95

    52-Week Price Change

    n/a
    		 -39.67%

    50-Day Moving Average

    n/a
    		 7.81

    200-Day Moving Average

    n/a
    		 10.79

    Relative Strength Index (RSI)

    n/a
    		 60.89

    Average Volume (20 Days)

    n/a
    		 1,143,414

    Income Statement

    In the last 12 months, Immunome had revenue of 9.04M and earned -292.96M in profits. Earnings per share was -5.

    Revenue

    n/a
    		 9.04M

    Gross Profit

    n/a
    		 9.04M

    Operating Income

    n/a
    		 -305.8M

    Net Income

    n/a
    		 -292.96M

    EBITDA

    n/a
    		 -151.35M

    EBIT

    n/a
    		 -153.46M

    Earnings Per Share (EPS)

    n/a
    		 -5
    Full Income Statement

    Balance Sheet

    The company has 143.35M in cash and 4.83M in debt, giving a net cash position of 138.52M.

    Cash & Cash Equivalents

    n/a
    		 143.35M

    Total Debt

    n/a
    		 4.83M

    Net Cash

    n/a
    		 138.52M

    Retained Earnings

    n/a
    		 -515.77M

    Total Assets

    n/a
    		 342.69M

    Working Capital

    n/a
    		 292.33M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -110.79M and capital expenditures -7.17M, giving a free cash flow of -117.97M.

    Operating Cash Flow

    n/a
    		 -110.79M

    Capital Expenditures

    n/a
    		 -7.17M

    Free Cash Flow

    n/a
    		 -117.97M

    FCF Per Share

    n/a
    		 -2.01
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -3382.37% and -3240.38%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -3382.37%

    Pretax Margin

    n/a
    		 -3240.38%

    Profit Margin

    n/a
    		 -3240.38%

    EBITDA Margin

    n/a
    		 -1674.08%

    EBIT Margin

    n/a
    		 -3382.37%

    FCF Margin

    n/a
    		 -1304.8%

    Dividends & Yields

    IMNM does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for IMNM is $25, which is 173.5% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $25

    Price Target Difference

    n/a
    		 173.5%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 5
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 9.89

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist